Bio/Pharma Business

Meletios Therapeutics’ Efforts in Antiviral Field Gains Recognition from Bpifrance

July 06, 2023

Meletios Therapeutics has been awarded with funding worth €1.2 million (US$1.3 million) from Bpifrance’s Deeptech development program.

Innovation Idolatry

July 02, 2023

If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.

Drug Pricing’s Static Changes

July 02, 2023

The debate surrounding drug pricing changes rages on.

Donaldson Company Acquires Univercells Technologies for €136 Million

June 30, 2023

Donaldson Company’s €136 million (US$148 million) acquisition of Univercells is designed to broaden its portfolio of biomanufacturing solutions.

Investigating Incubators & Innovation with Mason Ailstock

June 30, 2023

Mason Ailstock, CEO of the Rowen Foundation, discusses incubators and their potential to promote innovation.

Sobi and CTI BioPharma Complete $1.7 Billion Acquisition Deal

June 29, 2023

Sobi has officially acquired CTI, a biopharma company focused on blood related cancers and rare diseases, in a merger valued at approximately $1.7 billion.

Maurice Michel of Sweden Wins 2023 Eppendorf Award for Young European Investigators

June 26, 2023

The prestigious award, worth €20,000 (US$22,000), goes to Maurice Michel of the Science for Life Laboratory at Karolinska Institutet, Stockholm, Sweden.

Saudi Arabia’ PIF Launches Lifera, a New CDMO

June 21, 2023

PIF has established Lifera, a new manufacturing entity that will manufacture, stockpile, and supply bio/pharmaceuticals both locally and through partnerships.

Enzene Biosciences Invests $50 Million into New Jersey Biomanufacturing Facility

June 21, 2023

India’s Enzene Biosciences is investing $50 Million into a new biopharma manufacturing plant in Hopewell, NJ.

Lilly Enters Gene Editing Collaboration with Verve Therapeutics

June 20, 2023

Eli Lilly & Company will pay Verve Therapeutics up to $525 million to advance a lipoprotein gene editing research program.